HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Christina Westmose Yde Selected Research

Alemtuzumab (Campath)

12/2020Combining epigenetic therapy with venetoclax overcomes alemtuzumab resistance in T-cell prolymphocytic leukemia. A case report of a 26-year-old man with a prior history of T-cell acute lymphoblastic leukemia and GI-T lymphoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Christina Westmose Yde Research Topics

Disease

15Neoplasms (Cancer)
02/2023 - 06/2007
4Melanoma (Melanoma, Malignant)
10/2022 - 08/2018
3Breast Neoplasms (Breast Cancer)
10/2007 - 12/2006
2Glioblastoma (Glioblastoma Multiforme)
05/2024 - 01/2019
1Colorectal Neoplasms (Colorectal Cancer)
12/2022
1T-Cell Prolymphocytic Leukemia (Leukemia, T Cell, Chronic)
12/2020
1Rheumatoid Arthritis
08/2020
1Disease Progression
08/2018
1Brain Neoplasms (Brain Tumor)
10/2016
1Astrocytoma (Pilocytic Astrocytoma)
10/2016

Drug/Important Bio-Agent (IBA)

2NivolumabIBA
05/2024 - 10/2021
2RNA (Ribonucleic Acid)IBA
02/2023 - 01/2019
2Biomarkers (Surrogate Marker)IBA
02/2023 - 01/2023
2Circulating Tumor DNAIBA
12/2022 - 08/2018
2Cell-Free Nucleic AcidsIBA
01/2019 - 08/2018
2Proteins (Proteins, Gene)FDA Link
10/2007 - 12/2006
2Estrogen Receptor Modulators (Antiestrogen)IBA
10/2007 - 06/2007
2Cisplatin (Platino)FDA LinkGeneric
06/2007 - 12/2006
1Immune Checkpoint InhibitorsIBA
01/2023
1encorafenibIBA
12/2022
1Cetuximab (Erbitux)FDA Link
12/2022
1Codon (Codons)IBA
12/2022
1Histocompatibility Antigens Class IIBA
10/2022
1Janus Kinase 1IBA
10/2022
1Cancer VaccinesIBA
01/2022
1Peptides (Polypeptides)IBA
01/2022
1VaccinesIBA
01/2022
1IpilimumabIBA
10/2021
1IntegrinsIBA
10/2021
1Alemtuzumab (Campath)FDA Link
12/2020
1venetoclaxIBA
12/2020
1MicroRNAs (MicroRNA)IBA
08/2020
1Poly(ADP-ribose) Polymerase InhibitorsIBA
01/2019
1Indicators and Reagents (Reagents)IBA
08/2018
1CrizotinibIBA
01/2017
1Phosphotransferases (Kinase)IBA
10/2016
1Mitogen-Activated Protein KinasesIBA
10/2016
1Casein Kinase II (Casein Kinase 2)IBA
10/2007
1CaspasesIBA
10/2007
1TamoxifenFDA LinkGeneric
10/2007
1Estrogen ReceptorsIBA
06/2007
1Cyclin D1IBA
12/2006

Therapy/Procedure

6Therapeutics
02/2023 - 08/2018
4Immunotherapy
05/2024 - 10/2022
1Cell- and Tissue-Based Therapy (Cell Therapy)
10/2021
1Precision Medicine
01/2017